Mayor Jim Brainard’s vision to turn Carmel into a performing arts hub anchored by a world-class concert hall has come true, but without the support of central Indiana’s most important arts funder.
The Indianapolis-based private foundation announced Wednesday that Robert L. Smith will succeed Wallace “Ace” Yakey Jr., who is retiring June 30 after serving in the position since 2012.
Super Service Challenge, a national not-for-profit aimed at helping charities raise money and in-kind contributions, is launching a new e-platform designed by Indianapolis-based Sells Group meant to connect companies, volunteers and not-for-profits in a whole new way.
A $44 million VC infusion in 2017 for biosciences firm On Target Laboratories was one indication that Indiana’s life sciences sector is finally starting to pull down some serious venture funding.
Derica Rice, 53, one of the nation’s most powerful black executives, retired from Indianapolis-based drugmaker Eli Lilly and Co. in December, after the company passed him over when naming a new CEO.
The utility is asking state regulators for permission to increase the “fixed charge” on its 490,000 customers from $17 to $27 a month, and increase energy-usage charges also.
The company’s board is asking shareholders to support two corporate-governance proposals, including one that would eliminate a requirement that buyout bids garner at least 80 percent shareholder approval.
Chris Handberg, 38, worked at the Domestic Violence Network, The Julian Center and as a youth pastor in Anderson before becoming executive director of Indy Pride.
FDA Commissioner Scott Gottlieb aimed particular criticism at giant pharmacy benefit managers that contract with health plans to administer coverage of drugs, saying the industry’s tactics have stymied cheaper copies of expensive biotechnology drugs.
A Fishers native and Butler University graduate has been hired to succeed senior vice president Bill Benner, a longtime fixture in the local sports community.
Roche Holding AG—the Basel, Switzerland-based parent of Indianapolis-based Roche Diagnostics—has enlisted a little green gremlin to help rescue its diabetes business after a decade of declining sales.
The improvisation-based company—now known as CSz Indianapolis—just celebrated its 25th year of making-it-up-as-it-goes-along fun. Along the way, it has weathered location shifts, the recession, the post-9/11 comedy crisis and, recently, an ownership change to become the longest-running theater production in the city.
The Food and Drug Administration proposal will create new opportunities for drugmakers after repeated failures from companies including Indianapolis-based Eli Lilly and Co.
The Indianapolis-based drugmaker said the medicine, called Taltz, proved effective for treating a type of back stiffness, and hopes to submit it for government approval this year.
In 57 of its 58 years, Indianapolis-based Markey’s Rental & Staging has experienced year-over-year revenue increases. Only the Great Recession, in 2009, derailed Markey’s amazing streak.
